C-MER Medical Holdings Limited (Stock Code: 03309) filed a Next Day Disclosure Return on 13 November 2025 regarding on-market share repurchases. According to the announcement, the company repurchased 180,000 shares on 13 November 2025 at prices ranging from HKD 1.82 to HKD 1.84 per share, resulting in a total cost of HKD 329,320 and a volume-weighted average price per share of approximately HKD 1.8296.

Following the repurchase, the company holds 1,239,652,870 shares in issue (excluding treasury shares) and 15,908,000 shares in treasury, maintaining a total of 1,255,560,870 shares. As stated, these repurchases fall under the mandate approved on 19 May 2025, which authorizes repurchases of up to 125,556,087 shares. The disclosed transaction represents approximately 0.0145% of the shares in issue as at the date of that mandate.

The announcement also outlines a series of share repurchases for cancellation that occurred between July 2024 and May 2025, but which have not yet been formally cancelled. The company indicates a moratorium period up to 13 December 2025 for new share issuances or transfers of treasury shares following the repurchases.